|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | |
| C07K 14/605 | |||
| A61K 38/26 | |||
| C07H 15/04 | |||
| A61P 3/10 |
| (11) | Number of the document | 2710031 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12785861.1 |
| Date of filing the European patent application | 2012-05-17 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/038434 |
| Date | 2012-05-17 |
| (87) | Number | WO 2012/158965 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161487640 P | 2011-05-18 | US | |
| 201161543716 P | 2011-10-05 | US |
| (72) |
NESTOR, John, J., US
|
| (73) |
Mederis Diabetes, LLC,
725 Lynwood Drive, Encinitas, CA 92024,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |
| IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |